The two separate Morphine Sulfate monographs (General, and End of Life) have been combined into one monograph. Breathlessness at end of life is now included as a new indication, following a review of the use of morphine during the COVID-19 pandemic, and as per the NASMeD guidance that was issued on JRCALC Plus in April 2020. New cautions and dosages have been added for patients under 50kg and for frail and/or older adults.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.